August, 2021 , Pharma Manufacturing
To achieve true sustainability, a more holistic approach to overall drug development is needed
By: Simon Tyler
June, 2021 , One Nucleus
Our Talent Lead, Seb York discusses how employers need to create an inclusive and supportive environment for their teams
By: Seb York
June, 2021 , Pharma's Almanac
The broader suite of computer-aided synthesis planning tools is increasingly catching up with chemists in its ability to establish the most suitable way of putting together a target active pharmaceutical ingredient
By: Alan Steven
March, 2021 , The Medicine Maker
Technology transfer is full of risks. But risks can be mitigated with the right strategy and help from digital technologies
February, 2021 , The Medicine Maker
Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option
By: Alice Dunbabin
January, 2021 , The Small Molecule Manufacturer
Alan Steven explains why environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up
November, 2020 , The Medicine Maker
Our CEO, Dr Ross Burn talks about surviving and thriving as a new company focused on process chemistry, alongside more recent moves into industry 4.0 and collaborations in the contract research space
By: Ross Burn
September, 2020 , Chemistry Today
Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and contract manufacturing
July, 2020 , Chemistry Today
Our Associate Principal Scientist, Dr Vargini Thangavadivale participated in the latest Chemistry Today panel discussion on catalysis
By: Vargini Thangavadivale
July, 2020 , Mantell Associates Network
Our CEO, Dr Ross Burn spoke to the Mantell Associates Network podcast about innovation during the COVID-19 pandemic
